News
-
-
PRESS RELEASE
Preliminary figures for Medios AG 2024: Significant increase in earnings and margins – positive outlook for 2025
Medios AG reports significant increase in earnings and margins for 2024, positive outlook for 2025. Preliminary figures show revenue reaching €1.9 billion and EBITDA pre1 around €79 million -
PRESS RELEASE
AB Science: Article from the leading publication Life Sciences Magazine featuring masitinib and its Phase 3 principal investigator, the neurologist Patrick Vermersch
AB Science's masitinib and its phase 3 principal investigator, neurologist Patrick Vermersch, featured in Life Sciences Magazine for potential breakthrough in Progressive MS Treatment -
-
-
-
-
-
-